About
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. They aim to become a global leader in pain management by developing pharmaceutical products responsibly to maximize quality of life. Their portfolio includes FDA-approved products and pipeline candidates targeting various pain conditions.
Sector Focus
Pharmaceuticals
Life Sciences
Drug Discovery
Healthcare
Portfolio
Investment Activity
No timeline data for this period
Score Breakdown
18Deal Activity
0Track Record
0Visibility
2Profile
90Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Scilex Holding Company?
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. They aim to become a global leader in pain management by developing pharmaceutical products responsibly to maximize quality of life. Their portfolio includes FDA-approved products and pipeline candidates targeting various pain conditions.
Where is Scilex Holding Company based?
Scilex Holding Company is based in Palo Alto, US.
What sectors does Scilex Holding Company focus on?
Scilex Holding Company focuses on Pharmaceuticals, Life Sciences, Drug Discovery, Healthcare.
Similar Investors